Free Malaysia Today on MSN
Colorectal cancer and the importance of early screening
The second-most common cancer in Malaysia may not have symptoms, which is why experts advocate checkups for early detection.
17hon MSN
Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know
Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...
MedPage Today on MSN
Current Lung Cancer Screening Guidelines Miss Most Tumors, Study Suggests
Among 997 patients with lung cancer, only 35.1% met USPSTF screening criteria, while universal age-based screening (40-85 ...
A trace of blood in the stool, a mild stomach ache, and a persistent urge to pass motion. Most Malaysians would dismiss these ...
Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.
Madison-based Exact Sciences will be acquired by Abbott Laboratory for roughly $23 billion in a deal that was announced Nov.
Abbott said on Thursday it would buy cancer test maker Exact Sciences in a deal valued at up to $23 billion, including debt, ...
Simone Ledward Boseman secretly married Chadwick Boseman before his August 2020 death. Here's everything to know about ...
Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...
By bringing Exact Sciences into the fold, the expectation is that the focus on cancer diagnostics can provide a jolt to the ...
The medical-device giant's $21 bln acquisition of Exact Sciences will generate few synergies and only a 2% shorter-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results